Catalyst Wire Dossier Catalyst Wire Dossier

LUBIPROSTONE

lubiprostone · Camber Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

43 regulatory and trial events tracked for LUBIPROSTONE, covering 2007-05-16 to 2025-01-02. Get the full timeline:

Most recent: FDA Approved: LUBIPROSTONE — Original Application (Camber Pharmaceuticals, Inc.)

See pricing